Home Casteddu.com	FAQ My Amedeo About	Flying Publisher
	The Medical Article of the Year 2008

Malignant Melanoma

Free Subscription Articles published in Cancer Res Retrieve available abstracts of 164 articles: HTML format

Single Articles

June 2008
1. MONTAGUT C , Sharma SV, Shioda T, McDermott U, et al
   Elevated CRAF as a potential mechanism of acquired resistance to BRAF inhibition in melanoma.
   Cancer Res. 2008;68:4853-61.
   PubMed     Related articles    Abstract available
   
   
   
2. CRUZ-MUNOZ W , Man S, Xu P, Kerbel RS, et al
   Development of a preclinical model of spontaneous human melanoma central nervous system metastasis.
   Cancer Res. 2008;68:4500-5.
   PubMed     Related articles    Abstract available
   
   
   
3. MOLHOEK KR , Griesemann H, Shu J, Gershenwald JE, et al
   Human melanoma cytolysis by combined inhibition of mammalian target of rapamycin and vascular endothelial growth factor/vascular endothelial growth factor receptor-2.
   Cancer Res. 2008;68:4392-7.
   PubMed     Related articles    Abstract available
   
   
   May 2008
4. CONNEROTTE T , Van Pel A, Godelaine D, Tartour E, et al
   Functions of Anti-MAGE T-Cells Induced in Melanoma Patients under Different Vaccination Modalities.
   Cancer Res. 2008;68:3931-3940.
   PubMed     Related articles    Abstract available
   
   
   
5. AUGUSTINE CK , Yoshimoto Y, Gupta M, Zipfel PA, et al
   Targeting N-cadherin enhances antitumor activity of cytotoxic therapies in melanoma treatment.
   Cancer Res. 2008;68:3777-84.
   PubMed     Related articles    Abstract available
   
   
   
6. VAN KILSDONK JW , Wilting RH, Bergers M, van Muijen GN, et al
   Attenuation of Melanoma Invasion by a Secreted Variant of Activated Leukocyte Cell Adhesion Molecule.
   Cancer Res. 2008;68:3671-3679.
   PubMed     Related articles    Abstract available
   
   
   
7. CHEUNG M , Sharma A, Madhunapantula SV, Robertson GP, et al
   Akt3 and mutant V600E B-Raf cooperate to promote early melanoma development.
   Cancer Res. 2008;68:3429-39.
   PubMed     Related articles    Abstract available
   
   
   
8. DYNEK JN , Chan SM, Liu J, Zha J, et al
   Microphthalmia-associated transcription factor is a critical transcriptional regulator of melanoma inhibitor of apoptosis in melanomas.
   Cancer Res. 2008;68:3124-32.
   PubMed     Related articles    Abstract available
   
   
   
9. GOLDBERGER O , Volovitz I, Machlenkin A, Vadai E, et al
   Exuberated numbers of tumor-specific T cells result in tumor escape.
   Cancer Res. 2008;68:3450-7.
   PubMed     Related articles    Abstract available
   
   
   April 2008
10. FELICETTI F , Errico MC, Bottero L, Segnalini P, et al
    The promyelocytic leukemia zinc finger-microRNA-221/-222 pathway controls melanoma progression through multiple oncogenic mechanisms.
    Cancer Res. 2008;68:2745-54.
    PubMed     Related articles    Abstract available
    
    
    
11. SMYTH MJ , Teng MW, Sharkey J, Westwood JA, et al
    Interleukin 21 enhances antibody-mediated tumor rejection.
    Cancer Res. 2008;68:3019-25.
    PubMed     Related articles    Abstract available
    
    
    
12. EBERT LM , Tan BS, Browning J, Svobodova S, et al
    The regulatory T cell-associated transcription factor FoxP3 is expressed by tumor cells.
    Cancer Res. 2008;68:3001-9.
    PubMed     Related articles    Abstract available
    
    
    
13. EPARDAUD M , Elpek KG, Rubinstein MP, Yonekura AR, et al
    Interleukin-15/interleukin-15R alpha complexes promote destruction of established tumors by reviving tumor-resident CD8+ T cells.
    Cancer Res. 2008;68:2972-83.
    PubMed     Related articles    Abstract available
    
    
    
14. WAIBEL R , Treichler H, Schaefer NG, van Staveren DR, et al
    New derivatives of vitamin B12 show preferential targeting of tumors.
    Cancer Res. 2008;68:2904-11.
    PubMed     Related articles    Abstract available
    
    
    
15. GUTIERREZ-FERNANDEZ A , Fueyo A, Folgueras AR, Garabaya C, et al
    Matrix metalloproteinase-8 functions as a metastasis suppressor through modulation of tumor cell adhesion and invasion.
    Cancer Res. 2008;68:2755-63.
    PubMed     Related articles    Abstract available
    
    
    
16. PAVELKO KD , Heckman KL, Hansen MJ, Pease LR, et al
    An effective vaccine strategy protective against antigenically distinct tumor variants.
    Cancer Res. 2008;68:2471-8.
    PubMed     Related articles    Abstract available
    
    
    
17. JORRITSMA A , Bins AD, Schumacher TN, Haanen JB, et al
    Skewing the T-cell repertoire by combined DNA vaccination, host conditioning, and adoptive transfer.
    Cancer Res. 2008;68:2455-62.
    PubMed     Related articles    Abstract available
    
    
    March 2008
18. POS Z , Wiener Z, Pocza P, Racz M, et al
    Histamine suppresses fibulin-5 and insulin-like growth factor-II receptor expression in melanoma.
    Cancer Res. 2008;68:1997-2005.
    PubMed     Related articles    Abstract available
    
    
    
19. MACHLENKIN A , Uzana R, Frankenburg S, Eisenberg G, et al
    Capture of tumor cell membranes by trogocytosis facilitates detection and isolation of tumor-specific functional CTLs.
    Cancer Res. 2008;68:2006-13.
    PubMed     Related articles    Abstract available
    
    
    
20. ZHANG G , Njauw CN, Park JM, Naruse C, et al
    EphA2 is an essential mediator of UV radiation-induced apoptosis.
    Cancer Res. 2008;68:1691-6.
    PubMed     Related articles    Abstract available
    
    
    
21. JU T , Lanneau GS, Gautam T, Wang Y, et al
    Human tumor antigens Tn and sialyl Tn arise from mutations in Cosmc.
    Cancer Res. 2008;68:1636-46.
    PubMed     Related articles    Abstract available
    
    
    
22. COTE AL , Usherwood EJ, Turk MJ
    Tumor-specific T-cell memory: clearing the regulatory T-cell hurdle.
    Cancer Res. 2008;68:1614-7.
    PubMed     Related articles    Abstract available
    
    
    
23. BEMIS LT , Chen R, Amato CM, Classen EH, et al
    MicroRNA-137 targets microphthalmia-associated transcription factor in melanoma cell lines.
    Cancer Res. 2008;68:1362-8.
    PubMed     Related articles    Abstract available
    
    
    
24. SINI P , Samarzija I, Baffert F, Littlewood-Evans A, et al
    Inhibition of multiple vascular endothelial growth factor receptors (VEGFR) blocks lymph node metastases but inhibition of VEGFR-2 is sufficient to sensitize tumor cells to platinum-based chemotherapeutics.
    Cancer Res. 2008;68:1581-92.
    PubMed     Related articles    Abstract available
    
    
    February 2008
25. CRIPPA L , Gasparri A, Sacchi A, Ferrero E, et al
    Synergistic damage of tumor vessels with ultra low-dose endothelial-monocyte activating polypeptide-II and neovasculature-targeted tumor necrosis factor-alpha.
    Cancer Res. 2008;68:1154-61.
    PubMed     Related articles    Abstract available
    
    
    
26. CHEN LH , Jiang CC, Watts R, Thorne RF, et al
    Inhibition of endoplasmic reticulum stress-induced apoptosis of melanoma cells by the ARC protein.
    Cancer Res. 2008;68:834-42.
    PubMed     Related articles    Abstract available
    
    
    
27. VALLACCHI V , Daniotti M, Ratti F, Di Stasi D, et al
    CCN3/nephroblastoma overexpressed matricellular protein regulates integrin expression, adhesion, and dissemination in melanoma.
    Cancer Res. 2008;68:715-23.
    PubMed     Related articles    Abstract available
    
    
    
28. LIN WM , Baker AC, Beroukhim R, Winckler W, et al
    Modeling genomic diversity and tumor dependency in malignant melanoma.
    Cancer Res. 2008;68:664-73.
    PubMed     Related articles    Abstract available
    
    
    
29. HOEK KS , Eichhoff OM, Schlegel NC, Dobbeling U, et al
    In vivo switching of human melanoma cells between proliferative and invasive states.
    Cancer Res. 2008;68:650-6.
    PubMed     Related articles    Abstract available
    
    
    January 2008
30. SABATINO M , Zhao Y, Voiculescu S, Monaco A, et al
    Conservation of genetic alterations in recurrent melanoma supports the melanoma stem cell hypothesis.
    Cancer Res. 2008;68:122-31.
    PubMed     Related articles    Abstract available
    
    
    
31. MADHUNAPANTULA SV , Robertson GP
    Is B-Raf a good therapeutic target for melanoma and other malignancies?
    Cancer Res. 2008;68:5-8.
    PubMed     Related articles    Abstract available
    
    
    December 2007
32. LIAO YH , Hsu SM, Huang PH
    ARMS depletion facilitates UV irradiation induced apoptotic cell death in melanoma.
    Cancer Res. 2007;67:11547-56.
    PubMed     Related articles    Abstract available
    
    
    
33. SOLIT DB , Santos E, Pratilas CA, Lobo J, et al
    3'-deoxy-3'-[18F]fluorothymidine positron emission tomography is a sensitive method for imaging the response of BRAF-dependent tumors to MEK inhibition.
    Cancer Res. 2007;67:11463-9.
    PubMed     Related articles    Abstract available
    
    
    
34. SHEN L , Kondo Y, Ahmed S, Boumber Y, et al
    Drug sensitivity prediction by CpG island methylation profile in the NCI-60 cancer cell line panel.
    Cancer Res. 2007;67:11335-43.
    PubMed     Related articles    Abstract available
    
    
    
35. SEBESTYEN Z , de Vrij J, Magnusson M, Debets R, et al
    An oncolytic adenovirus redirected with a tumor-specific T-cell receptor.
    Cancer Res. 2007;67:11309-16.
    PubMed     Related articles    Abstract available
    
    
    November 2007
36. BLACKBURN JS , Rhodes CH, Coon CI, Brinckerhoff CE, et al
    RNA Interference Inhibition of Matrix Metalloproteinase-1 Prevents Melanoma Metastasis by Reducing Tumor Collagenase Activity and Angiogenesis.
    Cancer Res. 2007;67:10849-10858.
    PubMed     Related articles    Abstract available
    
    
    
37. ANDREANI V , Gatti G, Simonella L, Rivero V, et al
    Activation of Toll-like receptor 4 on tumor cells in vitro inhibits subsequent tumor growth in vivo.
    Cancer Res. 2007;67:10519-27.
    PubMed     Related articles    Abstract available
    
    
    
38. ZEISBERG EM , Potenta S, Xie L, Zeisberg M, et al
    Discovery of endothelial to mesenchymal transition as a source for carcinoma-associated fibroblasts.
    Cancer Res. 2007;67:10123-8.
    PubMed     Related articles    Abstract available
    
    
    
39. GRESHOCK J , Feng B, Nogueira C, Ivanova E, et al
    A comparison of DNA copy number profiling platforms.
    Cancer Res. 2007;67:10173-80.
    PubMed     Related articles    Abstract available
    
    
    October 2007
40. HUANG X , Yamada Y, Kidoya H, Naito H, et al
    EphB4 Overexpression in B16 Melanoma Cells Affects Arterial-Venous Patterning in Tumor Angiogenesis.
    Cancer Res. 2007;67:9800-8.
    PubMed     Related articles    Abstract available
    
    
    
41. HORTON LW , Yu Y, Zaja-Milatovic S, Strieter RM, et al
    Opposing roles of murine duffy antigen receptor for chemokine and murine CXC chemokine receptor-2 receptors in murine melanoma tumor growth.
    Cancer Res. 2007;67:9791-9.
    PubMed     Related articles    Abstract available
    
    
    
42. JIANG CC , Chen LH, Gillespie S, Wang YF, et al
    Inhibition of MEK Sensitizes Human Melanoma Cells to Endoplasmic Reticulum Stress-Induced Apoptosis.
    Cancer Res. 2007;67:9750-61.
    PubMed     Related articles    Abstract available
    
    
    
43. YANG B , O'Herrin SM, Wu J, Reagan-Shaw S, et al
    MAGE-A, mMage-b, and MAGE-C proteins form complexes with KAP1 and suppress p53-dependent apoptosis in MAGE-positive cell lines.
    Cancer Res. 2007;67:9954-62.
    PubMed     Related articles    Abstract available
    
    
    
44. SEYNHAEVE AL , Hoving S, Schipper D, Vermeulen CE, et al
    Tumor Necrosis Factor {alpha} Mediates Homogeneous Distribution of Liposomes in Murine Melanoma that Contributes to a Better Tumor Response.
    Cancer Res. 2007;67:9455-62.
    PubMed     Related articles    Abstract available
    
    
    
45. DENICOURT C , Saenz CC, Datnow B, Cui XS, et al
    Relocalized p27Kip1 Tumor Suppressor Functions as a Cytoplasmic Metastatic Oncogene in Melanoma.
    Cancer Res. 2007;67:9238-43.
    PubMed     Related articles    Abstract available
    
    
    
46. JONES R , Ruas M, Gregory F, Moulin S, et al
    A CDKN2A Mutation in Familial Melanoma that Abrogates Binding of p16INK4a to CDK4 but not CDK6.
    Cancer Res. 2007;67:9134-41.
    PubMed     Related articles    Abstract available
    
    
    
47. O'NEILL GM , Seo S, Serebriiskii IG, Lessin SR, et al
    A new central scaffold for metastasis: parsing HEF1/Cas-L/NEDD9.
    Cancer Res. 2007;67:8975-9.
    PubMed     Related articles    Abstract available
    
    
    September 2007
48. CHOI BK , Kim YH, Kang WJ, Lee SK, et al
    Mechanisms involved in synergistic anticancer immunity of anti-4-1BB and anti-CD4 therapy.
    Cancer Res. 2007;67:8891-9.
    PubMed     Related articles    Abstract available
    
    
    August 2007
49. PERROTTA C , Bizzozero L, Falcone S, Rovere-Querini P, et al
    Nitric Oxide Boosts Chemoimmunotherapy via Inhibition of Acid Sphingomyelinase in a Mouse Model of Melanoma.
    Cancer Res. 2007;67:7559-64.
    PubMed     Related articles    Abstract available
    
    
    
50. KO E , Luo W, Peng L, Wang X, et al
    Mouse dendritic-endothelial cell hybrids and 4-1BB costimulation elicit antitumor effects mediated by broad antiangiogenic immunity.
    Cancer Res. 2007;67:7875-84.
    PubMed     Related articles    Abstract available
    
    
    
51. HAUSNER SH , DiCara D, Marik J, Marshall JF, et al
    Use of a peptide derived from foot-and-mouth disease virus for the noninvasive imaging of human cancer: generation and evaluation of 4-[18F]fluorobenzoyl A20FMDV2 for in vivo imaging of integrin alphavbeta6 expression with positron emission tomography.
    Cancer Res. 2007;67:7833-40.
    PubMed     Related articles    Abstract available
    
    
    
52. MATTER M , Pavelic V, Pinschewer DD, Mumprecht S, et al
    Decreased tumor surveillance after adoptive T-cell therapy.
    Cancer Res. 2007;67:7467-76.
    PubMed     Related articles    Abstract available
    
    
    July 2007
53. HOU CC , Chen YP, Wu JH, Huang CC, et al
    A galactolipid possesses novel cancer chemopreventive effects by suppressing inflammatory mediators and mouse b16 melanoma.
    Cancer Res. 2007;67:6907-15.
    PubMed     Related articles    Abstract available
    
    
    
54. PALMER MB , Majumder P, Green MR, Wade PA, et al
    A 3' enhancer controls snail expression in melanoma cells.
    Cancer Res. 2007;67:6113-20.
    PubMed     Related articles    Abstract available
    
    
    
55. ZHANG P , Cote AL, de Vries VC, Usherwood EJ, et al
    Induction of postsurgical tumor immunity and T-cell memory by a poorly immunogenic tumor.
    Cancer Res. 2007;67:6468-76.
    PubMed     Related articles    Abstract available
    
    
    
56. SASAKI K , Zhu X, Vasquez C, Nishimura F, et al
    Preferential expression of very late antigen-4 on type 1 CTL cells plays a critical role in trafficking into central nervous system tumors.
    Cancer Res. 2007;67:6451-8.
    PubMed     Related articles    Abstract available
    
    
    June 2007
57. STRUYF S , Burdick MD, Peeters E, Van den Broeck K, et al
    Platelet Factor-4 Variant Chemokine CXCL4L1 Inhibits Melanoma and Lung Carcinoma Growth and Metastasis by Preventing Angiogenesis.
    Cancer Res. 2007;67:5940-8.
    PubMed     Related articles    Abstract available
    
    
    
58. JIANG CC , Chen LH, Gillespie S, Kiejda KA, et al
    Tunicamycin Sensitizes Human Melanoma Cells to Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand-Induced Apoptosis by Up-regulation of TRAIL-R2 via the Unfolded Protein Response.
    Cancer Res. 2007;67:5880-8.
    PubMed     Related articles    Abstract available
    
    
    
59. LIANG S , Sharma A, Peng HH, Robertson G, et al
    Targeting Mutant (V600E) B-Raf in Melanoma Interrupts Immunoediting of Leukocyte Functions and Melanoma Extravasation.
    Cancer Res. 2007;67:5814-20.
    PubMed     Related articles    Abstract available
    
    
    
60. MORGAN R , Pirard PM, Shears L, Sohal J, et al
    Antagonism of HOX/PBX Dimer Formation Blocks the In vivo Proliferation of Melanoma.
    Cancer Res. 2007;67:5806-13.
    PubMed     Related articles    Abstract available
    
    
    
61. YANG G , Curley D, Bosenberg MW, Tsao H, et al
    Loss of xeroderma pigmentosum C (xpc) enhances melanoma photocarcinogenesis in ink4a-arf-deficient mice.
    Cancer Res. 2007;67:5649-57.
    PubMed     Related articles    Abstract available
    
    
    
62. RASKOVALOVA T , Lokshin A, Huang X, Su Y, et al
    Inhibition of cytokine production and cytotoxic activity of human antimelanoma specific CD8+ and CD4+ T lymphocytes by adenosine-protein kinase A type I signaling.
    Cancer Res. 2007;67:5949-56.
    PubMed     Related articles    Abstract available
    
    
    
63. KOBAYASHI H , Nagato T, Sato K, Aoki N, et al
    Recognition of Prostate and Melanoma Tumor Cells by Six-Transmembrane Epithelial Antigen of Prostate-Specific Helper T Lymphocytes in a Human Leukocyte Antigen Class II-Restricted Manner.
    Cancer Res. 2007;67:5498-504.
    PubMed     Related articles    Abstract available
    
    
    
64. IVANOV VN , Zhou H, Hei TK
    Sequential Treatment by Ionizing Radiation and Sodium Arsenite Dramatically Accelerates TRAIL-Mediated Apoptosis of Human Melanoma Cells.
    Cancer Res. 2007;67:5397-407.
    PubMed     Related articles    Abstract available
    
    
    
65. SCHWARTZ B , Shoseyov O, Melnikova VO, McCarty M, et al
    ACTIBIND, a T2 RNase, Competes with Angiogenin and Inhibits Human Melanoma Growth, Angiogenesis, and Metastasis.
    Cancer Res. 2007;67:5258-66.
    PubMed     Related articles    Abstract available
    
    
    
66. THOMAS J , Liu T, Cotter MA, Florell SR, et al
    Melanocyte Expression of Survivin Promotes Development and Metastasis of UV-Induced Melanoma in HGF-Transgenic Mice.
    Cancer Res. 2007;67:5172-8.
    PubMed     Related articles    Abstract available
    
    
    
67. SAVAI R , Schermuly RT, Pullamsetti SS, Schneider M, et al
    A combination hybrid-based vaccination/adoptive cellular therapy to prevent tumor growth by involvement of T cells.
    Cancer Res. 2007;67:5443-53.
    PubMed     Related articles    Abstract available
    
    
    
68. OH SM , Zhu F, Cho YY, Lee KW, et al
    T-lymphokine-activated killer cell-originated protein kinase functions as a positive regulator of c-Jun-NH2-kinase 1 signaling and H-Ras-induced cell transformation.
    Cancer Res. 2007;67:5186-94.
    PubMed     Related articles    Abstract available
    
    
    May 2007
69. PREYNAT-SEAUVE O , Contassot E, Schuler P, Piguet V, et al
    Extralymphatic tumors prepare draining lymph nodes to invasion via a T-cell cross-tolerance process.
    Cancer Res. 2007;67:5009-16.
    PubMed     Related articles    Abstract available
    
    
    
70. WANG XY , Facciponte J, Chen X, Subjeck JR, et al
    Scavenger receptor-A negatively regulates antitumor immunity.
    Cancer Res. 2007;67:4996-5002.
    PubMed     Related articles    Abstract available
    
    
    
71. BOSCH JJ , Thompson JA, Srivastava MK, Iheagwara UK, et al
    MHC Class II-Transduced Tumor Cells Originating in the Immune-Privileged Eye Prime and Boost CD4+ T Lymphocytes that Cross-react with Primary and Metastatic Uveal Melanoma Cells.
    Cancer Res. 2007;67:4499-506.
    PubMed     Related articles    Abstract available
    
    
    
72. AKALU A , Roth JM, Caunt M, Policarpio D, et al
    Inhibition of angiogenesis and tumor metastasis by targeting a matrix immobilized cryptic extracellular matrix epitope in laminin.
    Cancer Res. 2007;67:4353-63.
    PubMed     Related articles    Abstract available
    
    
    April 2007
73. PASMANT E , Laurendeau I, Heron D, Vidaud M, et al
    Characterization of a Germ-Line Deletion, Including the Entire INK4/ARF Locus, in a Melanoma-Neural System Tumor Family: Identification of ANRIL, an Antisense Noncoding RNA Whose Expression Coclusters with ARF.
    Cancer Res. 2007;67:3963-9.
    PubMed     Related articles    Abstract available
    
    
    
74. MADHUNAPANTULA SV , Sharma A, Robertson GP
    PRAS40 Deregulates Apoptosis in Malignant Melanoma.
    Cancer Res. 2007;67:3626-36.
    PubMed     Related articles    Abstract available
    
    
    
75. SWOBODA RK , Somasundaram R, Caputo L, Ochoa EM, et al
    Shared MHC Class II-Dependent Melanoma Ribosomal Protein L8 Identified by Phage Display.
    Cancer Res. 2007;67:3555-9.
    PubMed     Related articles    Abstract available
    
    
    
76. BALAKRISHNAN A , Bleeker FE, Lamba S, Rodolfo M, et al
    Novel Somatic and Germline Mutations in Cancer Candidate Genes in Glioblastoma, Melanoma, and Pancreatic Carcinoma.
    Cancer Res. 2007;67:3545-3550.
    PubMed     Related articles    Abstract available
    
    
    
77. BARTHOLOMEUSZ G , Talpaz M, Bornmann W, Kong LY, et al
    Degrasyn activates proteasomal-dependent degradation of c-Myc.
    Cancer Res. 2007;67:3912-8.
    PubMed     Related articles    Abstract available
    
    
    
78. COHEN CJ , Li YF, El-Gamil M, Robbins PF, et al
    Enhanced antitumor activity of T cells engineered to express T-cell receptors with a second disulfide bond.
    Cancer Res. 2007;67:3898-903.
    PubMed     Related articles    Abstract available
    
    
    
79. ALONSO SR , Tracey L, Ortiz P, Perez-Gomez B, et al
    A high-throughput study in melanoma identifies epithelial-mesenchymal transition as a major determinant of metastasis.
    Cancer Res. 2007;67:3450-60.
    PubMed     Related articles    Abstract available
    
    
    
80. KUMAR SM , Yu H, Edwards R, Chen L, et al
    Mutant V600E BRAF Increases Hypoxia Inducible Factor-1{alpha} Expression in Melanoma.
    Cancer Res. 2007;67:3177-84.
    PubMed     Related articles    Abstract available
    
    
    
81. YANG J , Pan WH, Clawson GA, Richmond A, et al
    Systemic Targeting Inhibitor of {kappa}B Kinase Inhibits Melanoma Tumor Growth.
    Cancer Res. 2007;67:3127-3134.
    PubMed     Related articles    Abstract available
    
    
    
82. FAGIANI E , Giardina G, Luzi L, Cesaroni M, et al
    RaLP, a New Member of the Src Homology and Collagen Family, Regulates Cell Migration and Tumor Growth of Metastatic Melanomas.
    Cancer Res. 2007;67:3064-73.
    PubMed     Related articles    Abstract available
    
    
    March 2007
83. DIAZ RM , Galivo F, Kottke T, Wongthida P, et al
    Oncolytic immunovirotherapy for melanoma using vesicular stomatitis virus.
    Cancer Res. 2007;67:2840-8.
    PubMed     Related articles    Abstract available
    
    
    
84. STARK M , Hayward N
    Genome-wide loss of heterozygosity and copy number analysis in melanoma using high-density single-nucleotide polymorphism arrays.
    Cancer Res. 2007;67:2632-42.
    PubMed     Related articles    Abstract available
    
    
    
85. CORAL S , Sigalotti L, Covre A, Nicolay HJ, et al
    5-AZA-2'-deoxycytidine in cancer immunotherapy: a mouse to man story.
    Cancer Res. 2007;67:2900-1.
    PubMed     Related articles   
    
    
    
86. JAVELAUD D , Mohammad KS, McKenna CR, Fournier P, et al
    Stable overexpression of smad7 in human melanoma cells impairs bone metastasis.
    Cancer Res. 2007;67:2317-24.
    PubMed     Related articles    Abstract available
    
    
    
87. NAMKOONG J , Shin SS, Lee HJ, Marin YE, et al
    Metabotropic glutamate receptor 1 and glutamate signaling in human melanoma.
    Cancer Res. 2007;67:2298-305.
    PubMed     Related articles    Abstract available
    
    
    
88. YANG Y , Yang S, Ye Z, Jaffar J, et al
    Tumor cells expressing anti-CD137 scFv induce a tumor-destructive environment.
    Cancer Res. 2007;67:2339-44.
    PubMed     Related articles    Abstract available
    
    
    
89. MORVAN D , Demidem A
    Metabolomics by proton nuclear magnetic resonance spectroscopy of the response to chloroethylnitrosourea reveals drug efficacy and tumor adaptive metabolic pathways.
    Cancer Res. 2007;67:2150-9.
    PubMed     Related articles    Abstract available
    
    
    February 2007
90. BOUKERCHE H , Su ZZ, Emdad L, Sarkar D, et al
    mda-9/Syntenin Regulates the Metastatic Phenotype in Human Melanoma Cells by Activating Nuclear Factor-{kappa}B.
    Cancer Res. 2007;67:1812-22.
    PubMed     Related articles    Abstract available
    
    
    
91. SPINELLA F , Rosano L, Di Castro V, Decandia S, et al
    Endothelin-1 and Endothelin-3 Promote Invasive Behavior via Hypoxia-Inducible Factor-1{alpha} in Human Melanoma Cells.
    Cancer Res. 2007;67:1725-34.
    PubMed     Related articles    Abstract available
    
    
    
92. SHIELDS JM , Thomas NE, Cregger M, Berger AJ, et al
    Lack of Extracellular Signal-Regulated Kinase Mitogen-Activated Protein Kinase Signaling Shows a New Type of Melanoma.
    Cancer Res. 2007;67:1502-1512.
    PubMed     Related articles    Abstract available
    
    
    
93. JIANG W , Mikochik PJ, Ra JH, Lei H, et al
    HIV Protease Inhibitor Nelfinavir Inhibits Growth of Human Melanoma Cells by Induction of Cell Cycle Arrest.
    Cancer Res. 2007;67:1221-7.
    PubMed     Related articles    Abstract available
    
    
    January 2007
94. KANG TH , Lee JH, Song CK, Han HD, et al
    Epigallocatechin-3-gallate enhances CD8+ T cell-mediated antitumor immunity induced by DNA vaccination.
    Cancer Res. 2007;67:802-11.
    PubMed     Related articles    Abstract available
    
    
    
95. HOU DY , Muller AJ, Sharma MD, DuHadaway J, et al
    Inhibition of indoleamine 2,3-dioxygenase in dendritic cells by stereoisomers of 1-methyl-tryptophan correlates with antitumor responses.
    Cancer Res. 2007;67:792-801.
    PubMed     Related articles    Abstract available
    
    
    
96. SMALLEY KS , Contractor R, Haass NK, Kulp AN, et al
    An organometallic protein kinase inhibitor pharmacologically activates p53 and induces apoptosis in human melanoma cells.
    Cancer Res. 2007;67:209-17.
    PubMed     Related articles    Abstract available
    
    
    
97. GRAY-SCHOPFER VC , Karasarides M, Hayward R, Marais R, et al
    Tumor necrosis factor-alpha blocks apoptosis in melanoma cells when BRAF signaling is inhibited.
    Cancer Res. 2007;67:122-9.
    PubMed     Related articles    Abstract available
    
    
    
98. NAIR S , Boczkowski D, Fassnacht M, Pisetsky D, et al
    Vaccination against the forkhead family transcription factor Foxp3 enhances tumor immunity.
    Cancer Res. 2007;67:371-80.
    PubMed     Related articles    Abstract available
    
    
    
99. THANARAJASINGAM U , Sanz L, Diaz R, Qiao J, et al
    Delivery of CCL21 to metastatic disease improves the efficacy of adoptive T-cell therapy.
    Cancer Res. 2007;67:300-8.
    PubMed     Related articles    Abstract available
    
    
    December 2006
100. ZERBINI LF , Czibere A, Wang Y, Correa RG, et al
     A Novel Pathway Involving Melanoma Differentiation Associated Gene-7/Interleukin-24 Mediates Nonsteroidal Anti-inflammatory Drug-Induced Apoptosis and Growth Arrest of Cancer Cells.
     Cancer Res. 2006;66:11922-31.
     PubMed     Related articles    Abstract available
     
     
     
101. LOEWE R , Valero T, Kremling S, Pratscher B, et al
     Dimethylfumarate impairs melanoma growth and metastasis.
     Cancer Res. 2006;66:11888-96.
     PubMed     Related articles    Abstract available
     
     
     
102. VERHAEGEN M , Bauer JA, Martin de la Vega C, Wang G, et al
     A Novel BH3 Mimetic Reveals a Mitogen-Activated Protein Kinase-Dependent Mechanism of Melanoma Cell Death Controlled by p53 and Reactive Oxygen Species.
     Cancer Res. 2006;66:11348-59.
     PubMed     Related articles    Abstract available
     
     
     
103. CHEN X , Lin J, Kanekura T, Su J, et al
     A Small Interfering CD147-Targeting RNA Inhibited the Proliferation, Invasiveness, and Metastatic Activity of Malignant Melanoma.
     Cancer Res. 2006;66:11323-30.
     PubMed     Related articles    Abstract available
     
     
     
104. MUTHUSAMY V , Duraisamy S, Bradbury CM, Hobbs C, et al
     Epigenetic silencing of novel tumor suppressors in malignant melanoma.
     Cancer Res. 2006;66:11187-93.
     PubMed     Related articles    Abstract available
     
     
     
105. YANAGISAWA K , Exley MA, Jiang X, Ohkochi N, et al
     Hyporesponsiveness to natural killer T-cell ligand alpha-galactosylceramide in cancer-bearing state mediated by CD11b+ Gr-1+ cells producing nitric oxide.
     Cancer Res. 2006;66:11441-6.
     PubMed     Related articles    Abstract available
     
     
     November 2006
106. BECKER D , Mihm MC, Hewitt SM, Sondak VK, et al
     Markers and Tissue Resources for Melanoma: Meeting Report.
     Cancer Res. 2006;66:10652-10657.
     PubMed     Related articles    Abstract available
     
     
     
107. EPPING MT , Bernards R
     A Causal Role for the Human Tumor Antigen Preferentially Expressed Antigen of Melanoma in Cancer.
     Cancer Res. 2006;66:10639-10642.
     PubMed     Related articles    Abstract available
     
     
     
108. HELLEBREKERS DM , Castermans K, Vire E, Dings RP, et al
     Epigenetic regulation of tumor endothelial cell anergy: silencing of intercellular adhesion molecule-1 by histone modifications.
     Cancer Res. 2006;66:10770-7.
     PubMed     Related articles    Abstract available
     
     
     
109. CHAUDHRY UI , Kingham TP, Plitas G, Katz SC, et al
     Combined stimulation with interleukin-18 and CpG induces murine natural killer dendritic cells to produce IFN-gamma and inhibit tumor growth.
     Cancer Res. 2006;66:10497-504.
     PubMed     Related articles    Abstract available
     
     
     October 2006
110. COZZI SJ , Parsons PG, Ogbourne SM, Pedley J, et al
     Induction of Senescence in Diterpene Ester-Treated Melanoma Cells via Protein Kinase C-Dependent Hyperactivation of the Mitogen-Activated Protein Kinase Pathway.
     Cancer Res. 2006;66:10083-91.
     PubMed     Related articles    Abstract available
     
     
     
111. GOLDSTEIN AM , Chan M, Harland M, Gillanders EM, et al
     High-risk Melanoma Susceptibility Genes and Pancreatic Cancer, Neural System Tumors, and Uveal Melanoma across GenoMEL.
     Cancer Res. 2006;66:9818-28.
     PubMed     Related articles    Abstract available
     
     
     
112. YAGI H , Hashizume H, Horibe T, Yoshinari Y, et al
     Induction of therapeutically relevant cytotoxic T lymphocytes in humans by percutaneous peptide immunization.
     Cancer Res. 2006;66:10136-44.
     PubMed     Related articles    Abstract available
     
     
     
113. QIN JZ , Xin H, Sitailo LA, Denning MF, et al
     Enhanced Killing of Melanoma Cells by Simultaneously Targeting Mcl-1 and NOXA.
     Cancer Res. 2006;66:9636-45.
     PubMed     Related articles    Abstract available   Free Full Text
     
     
     
114. DUMAZ N , Hayward R, Martin J, Ogilvie L, et al
     In Melanoma, RAS Mutations Are Accompanied by Switching Signaling from BRAF to CRAF and Disrupted Cyclic AMP Signaling.
     Cancer Res. 2006;66:9483-91.
     PubMed     Related articles    Abstract available   Free Full Text
     
     
     September 2006
115. KANETSKY PA , Rebbeck TR, Hummer AJ, Panossian S, et al
     Population-based study of natural variation in the melanocortin-1 receptor gene and melanoma.
     Cancer Res. 2006;66:9330-7.
     PubMed     Related articles    Abstract available
     
     
     
116. KARST AM , Dai DL, Cheng JQ, Li G, et al
     Role of p53 Up-regulated Modulator of Apoptosis and Phosphorylated Akt in Melanoma Cell Growth, Apoptosis, and Patient Survival.
     Cancer Res. 2006;66:9221-9226.
     PubMed     Related articles    Abstract available
     
     
     
117. VALENTI R , Huber V, Filipazzi P, Pilla L, et al
     Human tumor-released microvesicles promote the differentiation of myeloid cells with transforming growth factor-beta-mediated suppressive activity on T lymphocytes.
     Cancer Res. 2006;66:9290-8.
     PubMed     Related articles    Abstract available
     
     
     
118. GAO K , Dai DL, Martinka M, Li G, et al
     Prognostic Significance of Nuclear Factor-{kappa}B p105/p50 in Human Melanoma and Its Role in Cell Migration.
     Cancer Res. 2006;66:8382-8.
     PubMed     Related articles    Abstract available   Free Full Text
     
     
     August 2006
119. SHARMA A , Tran MA, Liang S, Sharma AK, et al
     Targeting Mitogen-Activated Protein Kinase/Extracellular Signal-Regulated Kinase Kinase in the Mutant (V600E) B-Raf Signaling Cascade Effectively Inhibits Melanoma Lung Metastases.
     Cancer Res. 2006;66:8200-9.
     PubMed     Related articles    Abstract available   Free Full Text
     
     
     
120. GAO L , Feng Y, Bowers R, Becker-Hapak M, et al
     Ras-associated protein-1 regulates extracellular signal-regulated kinase activation and migration in melanoma cells: two processes important to melanoma tumorigenesis and metastasis.
     Cancer Res. 2006;66:7880-8.
     PubMed     Related articles    Abstract available   Free Full Text
     
     
     
121. POSTOVIT LM , Seftor EA, Seftor RE, Hendrix MJ, et al
     Influence of the microenvironment on melanoma cell fate determination and phenotype.
     Cancer Res. 2006;66:7833-6.
     PubMed     Related articles    Abstract available   Free Full Text
     
     
     
122. MLYNARCZUK-BIALY I , Roeckmann H, Kuckelkorn U, Schmidt B, et al
     Combined effect of proteasome and calpain inhibition on Cisplatin-resistant human melanoma cells.
     Cancer Res. 2006;66:7598-605.
     PubMed     Related articles    Abstract available
     
     
     
123. ROBERT G , Gaggioli C, Bailet O, Chavey C, et al
     SPARC Represses E-Cadherin and Induces Mesenchymal Transition during Melanoma Development.
     Cancer Res. 2006;66:7516-23.
     PubMed     Related articles    Abstract available
     
     
     
124. GOERGE T , Barg A, Schnaeker EM, Poppelmann B, et al
     Tumor-derived matrix metalloproteinase-1 targets endothelial proteinase-activated receptor 1 promoting endothelial cell activation.
     Cancer Res. 2006;66:7766-74.
     PubMed     Related articles    Abstract available
     
     
     July 2006
125. VAHA-KOSKELA MJ , Kallio JP, Jansson LC, Heikkila JE, et al
     Oncolytic capacity of attenuated replicative semliki forest virus in human melanoma xenografts in severe combined immunodeficient mice.
     Cancer Res. 2006;66:7185-94.
     PubMed     Related articles    Abstract available
     
     
     
126. CAPPUCCIO A , Elishmereni M, Agur Z
     Cancer immunotherapy by interleukin-21: potential treatment strategies evaluated in a mathematical model.
     Cancer Res. 2006;66:7293-300.
     PubMed     Related articles    Abstract available
     
     
     
127. DEN BROK MH , Sutmuller RP, Nierkens S, Bennink EJ, et al
     Synergy between in situ cryoablation and TLR9 stimulation results in a highly effective in vivo dendritic cell vaccine.
     Cancer Res. 2006;66:7285-92.
     PubMed     Related articles    Abstract available
     
     
     
128. ROFSTAD EK , Mathiesen B, Kindem K, Galappathi K, et al
     Acidic Extracellular pH Promotes Experimental Metastasis of Human Melanoma Cells in Athymic Nude Mice.
     Cancer Res. 2006;66:6699-707.
     PubMed     Related articles    Abstract available
     
     
     
129. MORI T , Martinez SR, O'day SJ, Morton DL, et al
     Estrogen Receptor-{alpha} Methylation Predicts Melanoma Progression.
     Cancer Res. 2006;66:6692-8.
     PubMed     Related articles    Abstract available
     
     
     
130. MIRMOHAMMADSADEGH A , Marini A, Nambiar S, Hassan M, et al
     Epigenetic Silencing of the PTEN Gene in Melanoma.
     Cancer Res. 2006;66:6546-52.
     PubMed     Related articles    Abstract available
     
     
     
131. PETTI C , Molla A, Vegetti C, Ferrone S, et al
     Coexpression of NRASQ61R and BRAFV600E in Human Melanoma Cells Activates Senescence and Increases Susceptibility to Cell-Mediated Cytotoxicity.
     Cancer Res. 2006;66:6503-11.
     PubMed     Related articles    Abstract available
     
     
     
132. CHUNG Y , Kim BS, Kim YJ, Ko HJ, et al
     CD1d-restricted T cells license B cells to generate long-lasting cytotoxic antitumor immunity in vivo.
     Cancer Res. 2006;66:6843-50.
     PubMed     Related articles    Abstract available
     
     
     June 2006
133. ANICHINI A , Mortarini R, Nonaka D, Molla A, et al
     Association of Antigen-Processing Machinery and HLA Antigen Phenotype of Melanoma Cells with Survival in American Joint Committee on Cancer Stage III and IV Melanoma Patients.
     Cancer Res. 2006;66:6405-11.
     PubMed     Related articles    Abstract available
     
     
     
134. ONIKI S , Nagai H, Horikawa T, Furukawa J, et al
     Interleukin-23 and interleukin-27 exert quite different antitumor and vaccine effects on poorly immunogenic melanoma.
     Cancer Res. 2006;66:6395-404.
     PubMed     Related articles    Abstract available
     
     
     
135. KOYANAGI K , Mori T, O'day SJ, Martinez SR, et al
     Association of circulating tumor cells with serum tumor-related methylated DNA in peripheral blood of melanoma patients.
     Cancer Res. 2006;66:6111-7.
     PubMed     Related articles    Abstract available
     
     
     
136. FURUTA J , Nobeyama Y, Umebayashi Y, Otsuka F, et al
     Silencing of peroxiredoxin 2 and aberrant methylation of 33 CpG islands in putative promoter regions in human malignant melanomas.
     Cancer Res. 2006;66:6080-6.
     PubMed     Related articles    Abstract available
     
     
     
137. MULLER-BERGHAUS J , Ehlert K, Ugurel S, Umansky V, et al
     Melanoma-reactive T cells in the bone marrow of melanoma patients: association with disease stage and disease duration.
     Cancer Res. 2006;66:5997-6001.
     PubMed     Related articles    Abstract available
     
     
     
138. ROZANOV DV , Savinov AY, Golubkov VS, Tomlinson S, et al
     Interference with the complement system by tumor cell membrane type-1 matrix metalloproteinase plays a significant role in promoting metastasis in mice.
     Cancer Res. 2006;66:6258-63.
     PubMed     Related articles    Abstract available
     
     
     
139. HOUGHTON AM , Grisolano JL, Baumann ML, Kobayashi DK, et al
     Macrophage elastase (matrix metalloproteinase-12) suppresses growth of lung metastases.
     Cancer Res. 2006;66:6149-55.
     PubMed     Related articles    Abstract available
     
     
     
140. VOO KS , Zeng G, Mu JB, Zhou J, et al
     CD4+ T-Cell Response to Mitochondrial Cytochrome b in Human Melanoma.
     Cancer Res. 2006;66:5919-26.
     PubMed     Related articles    Abstract available
     
     
     
141. GOLDKORN A , Blackburn EH
     Assembly of mutant-template telomerase RNA into catalytically active telomerase ribonucleoprotein that can act on telomeres is required for apoptosis and cell cycle arrest in human cancer cells.
     Cancer Res. 2006;66:5763-71.
     PubMed     Related articles    Abstract available
     
     
     
142. ZHANG L , Giraudo E, Hoffman JA, Hanahan D, et al
     Lymphatic zip codes in premalignant lesions and tumors.
     Cancer Res. 2006;66:5696-706.
     PubMed     Related articles    Abstract available
     
     
     May 2006
143. TORMO D , Ferrer A, Bosch P, Gaffal E, et al
     Therapeutic Efficacy of Antigen-Specific Vaccination and Toll-Like Receptor Stimulation against Established Transplanted and Autochthonous Melanoma in Mice.
     Cancer Res. 2006;66:5427-35.
     PubMed     Related articles    Abstract available
     
     
     
144. DI PUCCHIO T , Pilla L, Capone I, Ferrantini M, et al
     Immunization of Stage IV Melanoma Patients with Melan-A/MART-1 and gp100 Peptides plus IFN-{alpha} Results in the Activation of Specific CD8+ T Cells and Monocyte/Dendritic Cell Precursors.
     Cancer Res. 2006;66:4943-51.
     PubMed     Related articles    Abstract available
     
     
     
145. PEIKERT T , Specks U, Farver C, Erzurum SC, et al
     Melanoma antigen a4 is expressed in non-small cell lung cancers and promotes apoptosis.
     Cancer Res. 2006;66:4693-700.
     PubMed     Related articles    Abstract available
     
     
     
146. HEON SEO K , Ko HM, Kim HA, Choi JH, et al
     Platelet-Activating Factor Induces Up-regulation of Antiapoptotic Factors in a Melanoma Cell Line through Nuclear Factor-{kappa}B Activation.
     Cancer Res. 2006;66:4681-4686.
     PubMed     Related articles    Abstract available
     
     
     
147. ONKEN MD , Ehlers JP, Worley LA, Makita J, et al
     Functional gene expression analysis uncovers phenotypic switch in aggressive uveal melanomas.
     Cancer Res. 2006;66:4602-9.
     PubMed     Related articles    Abstract available
     
     
     
148. COHEN AD , Diab A, Perales MA, Wolchok JD, et al
     Agonist anti-GITR antibody enhances vaccine-induced CD8(+) T-cell responses and tumor immunity.
     Cancer Res. 2006;66:4904-12.
     PubMed     Related articles    Abstract available
     
     
     April 2006
149. LASFAR A , Lewis-Antes A, Smirnov SV, Anantha S, et al
     Characterization of the Mouse IFN-{lambda} Ligand-Receptor System: IFN-{lambda}s Exhibit Antitumor Activity against B16 Melanoma.
     Cancer Res. 2006;66:4468-77.
     PubMed     Related articles    Abstract available
     
     
     
150. GOTO Y , Matsuzaki Y, Kurihara S, Shimizu A, et al
     A new melanoma antigen Fatty Acid-binding protein 7, involved in proliferation and invasion, is a potential target for immunotherapy and molecular target therapy.
     Cancer Res. 2006;66:4443-9.
     PubMed     Related articles    Abstract available
     
     
     
151. SCHMITT E , Maingret L, Puig PE, Rerole AL, et al
     Heat shock protein 70 neutralization exerts potent antitumor effects in animal models of colon cancer and melanoma.
     Cancer Res. 2006;66:4191-7.
     PubMed     Related articles    Abstract available
     
     
     
152. LIU ZJ , Xiao M, Balint K, Smalley KS, et al
     Notch1 Signaling Promotes Primary Melanoma Progression by Activating Mitogen-Activated Protein Kinase/Phosphatidylinositol 3-Kinase-Akt Pathways and Up-regulating N-Cadherin Expression.
     Cancer Res. 2006;66:4182-90.
     PubMed     Related articles    Abstract available
     
     
     
153. NISHIMURA F , Dusak JE, Eguchi J, Zhu X, et al
     Adoptive transfer of type 1 CTL mediates effective anti-central nervous system tumor response: critical roles of IFN-inducible protein-10.
     Cancer Res. 2006;66:4478-87.
     PubMed     Related articles    Abstract available
     
     
     
154. CASATI C , Camisaschi C, Rini F, Arienti F, et al
     Soluble human LAG-3 molecule amplifies the in vitro generation of type 1 tumor-specific immunity.
     Cancer Res. 2006;66:4450-60.
     PubMed     Related articles    Abstract available
     
     
     
155. KAWAKAMI K , Terabe M, Kawakami M, Berzofsky JA, et al
     Characterization of a novel human tumor antigen interleukin-13 receptor alpha2 chain.
     Cancer Res. 2006;66:4434-42.
     PubMed     Related articles    Abstract available
     
     
     
156. MORITA N , Hiratsuka J, Kondoh H, Uno M, et al
     Improvement of the tumor-suppressive effect of boron neutron capture therapy for amelanotic melanoma by intratumoral injection of the tyrosinase gene.
     Cancer Res. 2006;66:3747-53.
     PubMed     Related articles    Abstract available
     
     
     
157. LUGINI L , Matarrese P, Tinari A, Lozupone F, et al
     Cannibalism of live lymphocytes by human metastatic but not primary melanoma cells.
     Cancer Res. 2006;66:3629-38.
     PubMed     Related articles    Abstract available
     
     
     
158. FUSHIMI T , O'Connor TP, Crystal RG
     Adenoviral gene transfer of stromal cell-derived factor-1 to murine tumors induces the accumulation of dendritic cells and suppresses tumor growth.
     Cancer Res. 2006;66:3513-22.
     PubMed     Related articles    Abstract available
     
     
     March 2006
159. REU FJ , Leaman DW, Maitra RR, Bae SI, et al
     Expression of RASSF1A, an epigenetically silenced tumor suppressor, overcomes resistance to apoptosis induction by interferons.
     Cancer Res. 2006;66:2785-93.
     PubMed     Related articles    Abstract available
     
     
     
160. VAN SCHANKE A , van Venrooij GM, Jongsma MJ, Banus HA, et al
     Induction of Nevi and Skin Tumors in Ink4a/Arf Xpa Knockout Mice by Neonatal, Intermittent, or Chronic UVB Exposures.
     Cancer Res. 2006;66:2608-15.
     PubMed     Related articles    Abstract available
     
     
     
161. GARRAWAY LA , Sellers WR
     From integrated genomics to tumor lineage dependency.
     Cancer Res. 2006;66:2506-8.
     PubMed     Related articles    Abstract available
     
     
     February 2006
162. AMIN DN , Hida K, Bielenberg DR, Klagsbrun M, et al
     Tumor endothelial cells express epidermal growth factor receptor (EGFR) but not ErbB3 and are responsive to EGF and to EGFR kinase inhibitors.
     Cancer Res. 2006;66:2173-80.
     PubMed     Related articles    Abstract available
     
     
     
163. BAUMGAERTNER P , Rufer N, Devevre E, Derre L, et al
     Ex vivo Detectable Human CD8 T-Cell Responses to Cancer-Testis Antigens.
     Cancer Res. 2006;66:1912-6.
     PubMed     Related articles    Abstract available
     
     
     
164. WANG J , Chin MY, Li G
     The novel tumor suppressor p33ING2 enhances nucleotide excision repair via inducement of histone H4 acetylation and chromatin relaxation.
     Cancer Res. 2006;66:1906-11.
     PubMed     Related articles    Abstract available
     
     

Thank you for your interest in scientific medicine.

Amedeo is a Bernd Sebastian Kamps website.    Design: